Aptamers in diagnostics: recognition built for the assay
Every diagnostic test begins with the same fundamental challenge: recognizing the right target in the right sample, with enough selectivity to generate a meaningful signal.
Aptamers offer a particularly flexible way to solve that problem. These synthetic DNA or RNA molecules can be developed to recognize proteins, cells and even small molecules, and their chemistry makes them easy to connect to fluorescent labels, electrodes, nanoparticles and other sensing elements. This has enabled aptamers to be incorporated into optical, electrochemical, colorimetric and lateral-flow detection systems.
That flexibility is important because the best binder is not simply the one with the highest affinity. It is the one that performs in the actual diagnostic format: serum, saliva, a lateral-flow strip, an electrode, a microfluidic system or another complex environment.
Some aptamers can go even further. Binding can be coupled to a change in molecular structure, effectively turning the aptamer into a molecular switch that converts target recognition into a detectable signal. This is one reason aptamers are being actively explored for portable and point-of-care biosensors.
For diagnostic development, the opportunity is therefore not simply to replace antibodies. It is to create a recognition element that can be selected and engineered around the needs of the assay itself.
Comments